Loading…
IceCure Medical Ltd is projected to rise to $3.56 by 2027, a +28% move from its current price of $2.78. ICCM is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $2.61 | $2.78 | $2.96 | +0.02% |
| Aug 6 | $2.54 | $2.78 | $3.05 | +0.04% |
| Aug 7 | $2.49 | $2.78 | $3.11 | +0.06% |
| Aug 8 | $2.45 | $2.78 | $3.16 | +0.08% |
| Aug 9 | $2.41 | $2.78 | $3.21 | +0.09% |
| Aug 10 | $2.38 | $2.78 | $3.26 | +0.11% |
| Aug 11 | $2.35 | $2.78 | $3.30 | +0.13% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.35 | $2.78 | $3.30 | +0.13% |
| Week 2 | $2.19 | $2.79 | $3.54 | +0.26% |
| Week 3 | $2.08 | $2.79 | $3.75 | +0.40% |
| Week 4 | $1.99 | $2.79 | $3.93 | +0.53% |
| Week 5 | $1.91 | $2.80 | $4.09 | +0.66% |
| Week 6 | $1.85 | $2.80 | $4.25 | +0.80% |
| Week 7 | $1.79 | $2.81 | $4.40 | +0.93% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
IceCure Medical Ltd is a commercial-stage medical device company that engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. Its product lineup includes the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, along with associated disposables such as CryoProbes needles and guiding needles/introducers; and the IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system, and MSense, a multi probe system for the treatment of multiple and larger tumors.
IceCure serves hospitals, interventional radiological centers, ambulatory centers, and private clinics. IceCure Medical Ltd was incorporated in 2006 and is headquartered in Caesarea, Israel.
IceCure Medical Ltd is a healthcare stock with the symbol ICCM. The current price is $2.79. Its market capitalization is $9.56M and it is ranked 4875 by market cap. The price outlook is guided by a year-by-year forecast with a mix of neutral and bullish sentiment in the near to long term.
In 2026, the avg price is $2.79 with ROI 0 and a neutral outlook. The forecast rises in subsequent years, with 2027 avg $3.59 (ROI 28.7, bullish) and 2028 avg $4.49 (ROI 60.9, bullish). By 2030 the avg is $3.16 (ROI 13.2, neutral), and sentiment remains bullish in many later years, culminating in 2050 avg $8.93 (ROI 220.2, bullish) with a max forecast of $20.55.
A major floor 95.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.4% away) — a key level to hold.
The nearest ceiling, 234.5% above — a clean break opens room to run.
A major ceiling 313.8% above — clearing it would confirm fresh momentum.
Key ICCM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ICCM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.87 | Sell | $2.93 | Sell |
| MA 10 | $3.07 | Sell | $3.10 | Sell |
| MA 20 | $3.46 | Sell | $3.40 | Sell |
| MA 50 | $3.32 | Sell | $3.14 | Sell |
| MA 100 | $1.85 | Buy | $2.39 | Buy |
| MA 200 | $1.26 | Buy | $1.73 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.03 | Neutral |
| Stoch RSI (14) | 18.84 | Buy |
| CCI (20) | -96.71 | Neutral |
| Williams %R (14) | -88.51 | Info |
| MACD (12,26,9) | -0.13 | Sell |
| ROC (12) | -19.72 | Sell |
| Bollinger %B (20,2) | 0.20 | Neutral |
| Stochastic %K (14) | 11.49 | Buy |
| TRIX (15) | -0.56 | Sell |
| Awesome (5,34) | -1.33 | Sell |
| Ultimate (7,14,28) | 20.36 | Buy |
| Momentum (10) | -0.76 | Sell |
| Aroon Osc (25) | -88.00 | Sell |
| Hull MA (9) | 2.77 | Buy |
| ADX (14) | 15.37 | Neutral |
| ATR (14) | 0.27 | Info |
The near-term technical picture is Bearish. The RSI(14) is 40, indicating weak momentum. The 50-day simple moving average sits at $4.86 and the 200-day simple moving average sits at $14.60.
There is support at $2.13 and resistance at $9.30, framing a price path that has recently ranged between $1.74 and $4.48 over the last 30 days. Annualized volatility is very high at 100%, underscoring substantial near-term fluctuations.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.13 | $2.78 | $4.23 | 0% | Neutral | |
| $2.60 | $3.56 | $5.28 | +28% | Bullish | |
| $3.04 | $4.43 | $7.02 | +59% | Bullish | |
| $2.58 | $3.97 | $6.60 | +43% | Bullish | |
| $1.97 | $3.17 | $5.50 | +14% | Neutral | |
| $2.05 | $3.46 | $6.20 | +24% | Bullish | |
| $1.92 | $3.38 | $6.25 | +22% | Bullish | |
| $2.29 | $4.20 | $7.98 | +51% | Bullish | |
| $2.69 | $5.12 | $9.99 | +84% | Bullish | |
| $2.50 | $4.95 | $9.87 | +78% | Bullish | |
| $2.89 | $6.43 | $14.10 | +131% | Bullish | |
| $4.06 | $9.01 | $20.73 | +224% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.13 | $2.78 | $3.70 | +0.00% |
| September 2026 | $2.38 | $2.89 | $3.67 | +4.13% |
| October 2026 | $2.29 | $2.83 | $3.66 | -2.29% |
| November 2026 | $2.46 | $3.06 | $4.03 | +8.27% |
| December 2026 | $2.52 | $3.17 | $4.23 | +3.51% |
Click any year to see its month-by-month ICCM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ICCM price prediction for 2026 points to an average of $2.78 (low $2.13, high $4.23) — a potential gain of 0% on today's $2.78. A consolidation phase looks the most probable path here.
In 2027, ICCM is projected to trade between $2.60 and $5.28, averaging $3.56 — a potential gain of +28% from today's $2.78. That is up +28% on the projected 2026 average. Momentum favours further upside here.
IceCure Medical Ltd's 2028 outlook centres on $4.43, within a $3.04 to $7.02 range. That is up +24% on the projected 2027 average. That marks a +59% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, ICCM could reach as high as $6.60, with a base case around $3.97 and support toward $2.58 — roughly +43% from $2.78. Momentum favours further upside here.
Expect ICCM to range from $1.97 to $5.50 through 2030. The $3.17 average target implies a +14% move from current prices. That is -20% versus the projected 2029 average. A consolidation phase looks the most probable path here.
The ICCM price prediction for 2031 points to an average of $3.46 (low $2.05, high $6.20) — a potential gain of +24% on today's $2.78. Momentum favours further upside here.
In 2032, ICCM is projected to trade between $1.92 and $6.25, averaging $3.38 — a potential gain of +22% from today's $2.78. That is -2% versus the projected 2031 average. Buyers look set to stay in control over this stretch.
IceCure Medical Ltd's 2033 outlook centres on $4.20, within a $2.29 to $7.98 range. That is up +24% on the projected 2032 average. That marks a +51% change versus current levels. Momentum favours further upside here.
By 2034, ICCM could reach as high as $9.99, with a base case around $5.12 and support toward $2.69 — roughly +84% from $2.78. Buyers look set to stay in control over this stretch.
Expect ICCM to range from $2.50 to $9.87 through 2035. The $4.95 average target implies a +78% move from current prices. That is -3% versus the projected 2034 average. Momentum favours further upside here.
The ICCM price prediction for 2040 points to an average of $6.43 (low $2.89, high $14.10) — a potential gain of +131% on today's $2.78. Buyers look set to stay in control over this stretch.
In 2050, ICCM is projected to trade between $4.06 and $20.73, averaging $9.01 — a potential gain of +224% from today's $2.78. That is up +40% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ICCM today (≈ 359.71223 ICCM) could be worth
$3,242.63
+$2,242.63 (+224%) by 2050 · US Dollar
Based on the average projected ICCM price of $9.01 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ICCMwould be worth at today's price.
$1,000 invested in ICCM on Jul 31, 2025 (≈ 980.392175 ICCM) would be worth
$2,725.49
+$1,725.49 (+172.5%) today · 2.73× · US Dollar
Based on a ICCM entry price of $1.02 vs. today's $2.78.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.08 | $902.6 | -9.7% |
| 1 month ago | $5.28 | $526.52 | -47.3% |
| 3 months ago | $0.301 | $9,235.88 | +823.6% |
| 6 months ago | $0.616 | $4,512.99 | +351.3% |
| 1 year ago | $1.02 | $2,725.49 | +172.5% |
| All time (5.0y) ago | $10.13 | $274.54 | -72.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ICCM forecast.
Our base-case forecast reaches $5.60 around 2040.
Implied market cap at $5.60: $19.19M
Across the multi-year horizon, the forecast shows potential upside with several bullish years after 2026. The average price for 2027 is $3.59 and 2028 is $4.49, with corresponding ROIs of 28.7 and 60.9, both labeled bullish. The 2030 average is $3.16 with ROI 13.2 and neutral sentiment, while 2040 averages at $6.56 with ROI 135 and bullish sentiment, and 2050 averages at $8.93 with ROI 220.2 and bullish sentiment.
The 2034 forecast projects a max of $10.16 and a min of $2.73, with an average of $5.21 and ROI 86.7; the 2040 and 2050 figures illustrate meaningful long-run upside despite near-term uncertainty.
Tap a question to reveal the answer.
The 2030 forecast shows a min of $1.96, an avg of $3.16, and a max of $5.47, with ROI 13.2 and sentiment NEUTRAL.
Long-term the outlook shows bullish momentum in many years beyond 2026, with 2040 avg $6.56 and ROI 135 and 2050 avg $8.93 with ROI 220.2, while 2026 remains neutral.
Yes—the forecast lists a 2034 max of $10.16.
Current price is $2.79 and market cap is $9.56M (rank 4875).
2034 min $2.73, avg $5.21, max $10.16; ROI 86.7; sentiment BULLISH.
IceCure Medical Ltd Community Discussion
0Share your IceCure Medical Ltd price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.